127 related articles for article (PubMed ID: 22187668)
1. DNA lesion bypass polymerases and 4'-thio-β-Darabinofuranosylcytosine (T-araC).
Chen YW; Chou KM
Int J Biochem Mol Biol; 2011; 2(4):340-6. PubMed ID: 22187668
[TBL] [Abstract][Full Text] [Related]
2. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
Someya H; Waud WR; Parker WB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.
Someya H; Shaddix SC; Tiwari KN; Secrist JA; Parker WB
J Pharmacol Exp Ther; 2003 Mar; 304(3):1314-22. PubMed ID: 12604712
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for polymerase η-promoted resistance to the anticancer nucleoside analog cytarabine.
Rechkoblit O; Choudhury JR; Buku A; Prakash L; Prakash S; Aggarwal AK
Sci Rep; 2018 Aug; 8(1):12702. PubMed ID: 30140014
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic activity of 4'-thio-beta-D-arabinofuranosylcytosine.
Roy AM; Tiwari KN; Parker WB; Secrist JA; Li R; Qu Z
Mol Cancer Ther; 2006 Sep; 5(9):2218-24. PubMed ID: 16985055
[TBL] [Abstract][Full Text] [Related]
7. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
[TBL] [Abstract][Full Text] [Related]
8. Replication bypass of N2-deoxyguanosine interstrand cross-links by human DNA polymerases η and ι.
Klug AR; Harbut MB; Lloyd RS; Minko IG
Chem Res Toxicol; 2012 Mar; 25(3):755-62. PubMed ID: 22332732
[TBL] [Abstract][Full Text] [Related]
9. Translesion synthesis DNA polymerases η, ι, and ν promote mutagenic replication through the anticancer nucleoside cytarabine.
Yoon JH; Roy Choudhury J; Prakash L; Prakash S
J Biol Chem; 2019 Dec; 294(50):19048-19054. PubMed ID: 31685662
[TBL] [Abstract][Full Text] [Related]
10. Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.
Richardson KA; Vega TP; Richardson FC; Moore CL; Rohloff JC; Tomkinson B; Bendele RA; Kuchta RD
Biochem Pharmacol; 2004 Dec; 68(12):2337-46. PubMed ID: 15548380
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
Gourdeau H; Bibeau L; Ouellet F; Custeau D; Bernier L; Bowlin T
Cancer Chemother Pharmacol; 2001 Mar; 47(3):236-40. PubMed ID: 11320667
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling of four Y-family, lesion-bypass DNA polymerases: the case that E. coli Pol IV and human Pol kappa are orthologs, and E. coli Pol V and human Pol eta are orthologs.
Lee CH; Chandani S; Loechler EL
J Mol Graph Model; 2006 Sep; 25(1):87-102. PubMed ID: 16386932
[TBL] [Abstract][Full Text] [Related]
14. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
[TBL] [Abstract][Full Text] [Related]
15. Translesion synthesis across O6-alkylguanine DNA adducts by recombinant human DNA polymerases.
Choi JY; Chowdhury G; Zang H; Angel KC; Vu CC; Peterson LA; Guengerich FP
J Biol Chem; 2006 Dec; 281(50):38244-56. PubMed ID: 17050527
[TBL] [Abstract][Full Text] [Related]
16. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
[TBL] [Abstract][Full Text] [Related]
17. DNA polymerases as targets of anticancer nucleosides.
Miura S; Izuta S
Curr Drug Targets; 2004 Feb; 5(2):191-5. PubMed ID: 15011952
[TBL] [Abstract][Full Text] [Related]
18. Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa.
Suzuki N; Yasui M; Santosh Laxmi YR; Ohmori H; Hanaoka F; Shibutani S
Biochemistry; 2004 Sep; 43(35):11312-20. PubMed ID: 15366941
[TBL] [Abstract][Full Text] [Related]
19. trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases.
Rechkoblit O; Zhang Y; Guo D; Wang Z; Amin S; Krzeminsky J; Louneva N; Geacintov NE
J Biol Chem; 2002 Aug; 277(34):30488-94. PubMed ID: 12063247
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N4-alkyl-1-beta-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5'-->5')-N4-octadecyl-1-beta-D-arabinofuranosylcytosi ne.
Horber DH; Cattaneo-Pangrazzi RM; von Ballmoos P; Schott H; Ludwig PS; Eriksson S; Fichtner I; Schwendener RA
J Cancer Res Clin Oncol; 2000 Jun; 126(6):311-9. PubMed ID: 10870640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
